Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Active, Not Recruiting

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

NCT05455658

Conditions
Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, +21 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

NCT06157892

Conditions
Advanced Breast Cancer, Advanced Gastric Cancer, Breast Diseases, +17 more
Locations
  • Banner-University Medical Center Tucson Campus Tucson, Arizona, United States
  • Banner-University Medical Center Tucson Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Pharmacy, Attn: Kelly Myrdal Tucson, Arizona, United States
  • University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer

NCT04052555

Conditions
Bilateral Breast Carcinoma, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

T-Cell Therapy for Advanced Breast Cancer

NCT02792114

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Memorial Sloan Kettering Cancer Center (Consent and follow-up only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and follow-up only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center at Commack (Consent and follow-up only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

NCT02276443

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +16 more
Locations
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson West Houston Houston, Texas, United States
  • MD Anderson League City League City, Texas, United States
View Trial Details
Active, Not Recruiting

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT06533059

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

NCT01116648

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard Fort Wayne, Indiana, United States
View all 14 locations
View Trial Details

Related conditions